Lumendi Achieves Key Milestone with Completion of DiLumen EZ¹ Customer Evaluations, Setting the Stage for the Next Phase of DiLumen Product Innovation WESTPORT, CT – July 27, 2023 Lumendi, a… Continue reading The 58th Florida Gastroenterologic Society Annual Conference
Lumendi Achieves Key Milestone with Completion of DiLumen EZ¹ Customer Evaluations, Setting the Stage for the Next Phase of DiLumen Product Innovation WESTPORT, CT – July 27, 2023 Lumendi, a… Continue reading EZ¹ successfully completes Customer Evaluation phase.
Endoscopic removal of colonic polyps and early cancers eliminates the need for surgical resection and possible temporary or permanent colostomy.
Award for the Balloon Endo-Luminal Lumen Occluding (BELLO) Device Presented to Dr. Maselli at the ESGE Days 2023 Congress Apr 20, 2023, 12:27 ET Lumendi Congratulates Dr. Maselli on the… Continue reading Dr. Roberta Maselli, receives innovation of the year award for the best new device from the ESGE
Lumendi, LLC has received U.S. Food and Drug Administration (FDA) 510(k) clearance for DiLumen EZ¹, a single-use, disposable endotherapy device for endoscopic mucosal resections (EMR) and difficult colonoscopies.
DiLumen EZ¹ The DiLumen EZ¹ is a variant of the DiLumen design, specially intended for the removal of complex polyps using the EMR* technique. Thanks to its unique balloon design,… Continue reading Expansion of the Dilumen Platform
Company Achieves New Milestone with 3,000 Therapeutic Procedures Completed Across U.S., Europe, and Asia Using DiLumen™ EIP DiLumen EZ¹ single balloon stabilization endotherapy device. (Photo: Business Wire) May 19, 2022… Continue reading Lumendi Files for 510(k) Clearance for Two New Products
Since the company’s inception, we have accumulated over 100 DiLumen users worldwide. Half of these physicians have begun using our devices in the last 12 to 18 months. This year’s DDW was our first opportunity in three years to present Lumendi and our significantly enhanced DiLumen platform to users and industry.
"Stability is perfect! Maneuverability with DiLumen EZ Glide is great and the conduit function facilitates easy re-access to the right colon." Prof. Dr. Peter Bauerfeind Stadtspital Triemli, Zürich, CH
“DiLumen EZ Glide provides me with effective and efficient access, which is why it is an essential ESD tool for me.” Dr. Alexander Schlachterman Thomas Jefferson University Hospital, Philadelphia,… Continue reading Dr. Alexander Schlachterman
“The new DiLumen EZ Glide significantly improved our ability to remove four cecal polyps in a recent case. We could not have ever done this without it.” Dr. Stuart Gordon… Continue reading Dr. Stuart Gordon
“EZ Glide represents a huge improvement in usability of DiLumen technology. The enhanced ease of use has prompted me to use DiLumen more often for complex colonic polypectomies.” Dr. David… Continue reading Geisinger Medical Center, Danville, PA
DiLumen EZ-Glide improves visibility and simplifies intraoperative
LUMENDI REPORTS SUCCESSFUL COMPLETION OF DILUMEN™ EIP FIRST-IN-HUMAN TRIALS Primary Study Endpoint Reached with no Serious Adverse Events WESTPORT, CONNECTICUT, November 16, 2017 – Connecticut-based medical device innovator Lumendi,… Continue reading Lumendi Reports Successful Completion Of Dilumen™ Eip First-in-human Trials
Thank you to Prof. Peter Bauerfeind and Dr. Hugo Uchima for a great workshop in Lucerne. The international group of endoscopists enjoyed the educational value and the practical experience of… Continue reading Thank you to Prof. Peter Bauerfeind and Dr. Hugo Uchima
Thank you for supporting our Patient Awareness Initiative
Dr. Peter Johann, CEO & Founder of Lumendi and Prof. Bauerfeind discussed how treatment methods such as EMR and ESD can be made more accessible to patients. Prof. Bauerfeind: "Sometimes these treatments… Continue reading 30% of surgical interventions are unnesessary
October 19, 2021 08:00 AM Eastern Daylight Time WESTPORT, Conn.--(BUSINESS WIRE)--Lumendi-- Effective October 1, 2021, the Centers for Medicare & Medicaid Services (CMS) established C9779 as a new Healthcare… Continue reading Lumendi Announces CMS HCPCS Code for Reimbursement of ESD Procedures Performed in Hospital Outpatient Facilities
DiLumen® Product Enhancement Launched in December 2020 on Track to Double Sales from Previous Year September 28, 2021 WESTPORT, Conn.--(BUSINESS WIRE)-- EZ Glide, the most recent enhancement to Lumendi’s DiLumen Endoluminal Interventional… Continue reading EZ Glide Pushes Lumendi to New Quarter-Over-Quarter Sales Record
INTRODUCING LUMENDI'S LATEST INNOVATION At Lumendi, we’re committed to creating technologies that enable physicians to perform at a higher level, minimize risk and recovery time for patients. We invite you… Continue reading Invitation Skills Lab, Switzerland
Innovative Surgical Platform Improves the Safety and Speed of Endolumenal Procedures For patients with complex benign colorectal polyps, surgical intervention tends to be the norm. Yet, endoluminal procedures like endoscopic… Continue reading Introducing Lumendi’s latest Innovation in Asia
Many studies have documented that an endoscopic approach for ESD is a safer and less expensive alternative to removing these polyps, leading to fewer postoperative complications and shorter hospital stays.
Superiority of DiLumen over traditional (non-overtube) ESD for complex colorectal polypectomy.
Removing colorectal polyps and early cancers by endoscope eliminates the need for surgical resection and the potential for colostomy. This study reports clear improvements in safety, dissection time, dissection speed, R0 resection rates (clean pathological margins), and navigation time over non-DiLumen-assisted (freehand) procedures.
The Cost-Effectiveness of DiLumenTM for Endoscopic Intervention of Complex Colonic Polyps
James White, D.O., VP of Medical Affairs, Lumendi
Karl Florence, Reimbursement Consultant.
Pioneering Endosurgery reflects Lumendi’s innovative, three-part pathway to:
expand indication areas and procedures in the upper gastrointestinal tract, which includes a recent submission to the FDA;
innovate improvements planned for the DiLumen EIP, including a proprietary lubricated inner surface of DiLumen’s sheath for better endoscope handling performance; and
commercially release the DiLumen C2 platform to bring robotic-like end-effectors to endolumenal surgery in a low-cost, disposable format to provide endoscopists with unprecedented control of tissue.
A study evaluating endoscopic procedure time removing complex colorectal polyps shows superiority of Lumendi’s DiLumen device over a control group.